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Abstract
Nanoparticle technology is gaining traction in many different industries, particularly in imaging
and the medical industries, and thus it becomes increasing important to understand how particles
will affect the body. This is why we want to look at the way nanoparticles interact with lipid
membranes, since lipids play vital roles in biological processes such as stabilizing the distal
airways in our lungs in low volume situations. Knowing how nanoparticles will interact with
these lipids can give us insights into the potential cytotoxicity of the particles, and how other
agents, such as viruses act near/on a lipid membrane. In this thesis, we look at Nanocapsules, to
determine the way they dock and aggregate on a lipid membrane.
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Chapter 1: Introduction
Lipid molecules are composed of three portions. One portion is polar and thus
hydrophilic called the head group. The other two portions are hydrophobic hydrocarbons known
as tail groups. Due to this construction, when placed in aqueous solution, the lipids quickly selfassemble into bilayers, where the tail groups are shielded from the water by the head groups. The
bilayer and different proteins comprise the plasma membrane, which plays an important role in
many biological processes. (28) (37)
At low temperatures, the bilayer is in gel phase, and transitions to a fluid phase as
temperature rises. In the fluid phase, the membranes allow for transport of a large variety of
transmembrane proteins, which act as gateways for other substances to pass through the
membrane. In the fluid phase, membranes also can more easily deform allowing for process such
as endocytosis, which is a form of active transport of molecules into a cell. (31) (62)

Figure 1: Representation of lipid bilayer, denoting head and tail groups
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The two separate layers of the of the lipid bilayer membrane, are not symmetric with each
other. (63) (64) The shape of the membrane, especially in vesicle form, is dramatically affected by
the asymmetry, in conjunction with factors like temperature and the size of the vesicle.(65) While
the molecule chain in each layer is held together by covalent bonds, the structure is held together
by forces such van der Waals forces, which are much weaker, granting movement in the plane of
the membrane. (30) (54) Membranes that form in places such as alveolus have tight membranes,
however, other pulmonary surfactants can be much looser. Many pulmonary surfactants are
composed of phospholipids, neutral lipids, and proteins, and the phospholipids are the ones that
form the film at the interface between liquid and air. The goal of these of membranes is provide
efficient gas follow, while optimizing the interaction with other molecules. (33) Knowing how
these surfactants function, interact, and form have already been immensely useful in therapeutic
trials for infants with Respiratory Distress Syndrome. (34)
The self-aggregation of lipids makes an appearance in many very important parts of
animal biology. For example, pertaining to the lungs, a complex of lipids and proteins stabilize
the distal airways in low volume situations. (32) And since lipids play a vital role in our bodies,
and are found almost everywhere in our bodies, it becomes important to determine how different
elements will affect them. In the case of the above example, researchers compare the aggregation
of lipids when their aggregation is induced by SP-A proteins to aggregation induced by
Ca2+.(32)(35)(36) This type of aggregation will also very through the use of different proteins as
well.(58)
Lipid Bilayers can take many different forms. An important form in the study of bilayers
is the vesicle. A vesicle is a comprised of a fluid surrounded/enclosed by a lipid bilayer. These
can form from processes like secretion and endocytosis. (55) This is a unique property of lipids
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because it allows for the encapsulation many different solutes. (38) These vesicles also allow
lipids to traverse different barriers in the body, in particular the skin. This makes lipid vesicles
attractive for topical skin applications. (39)(40) The vesicles can also pass through the plasma
membrane through endocytosis, but also through fusing with the plasma membrane (this path is
especially true for lipid vesicles primarily composed of phospholipids). (41)(46) With these
situations, we are primarily dealing with the lipid bilayers interacting with larger substances, but
other end of the spectrum also provides valuable insight which is focused on more heavily in the
later sections. A quick example is of anisotropically curved nanoparticles binding to lipid
vesicle, and the subsequent aggregation of the nanoparticles that occur. This is also true for
proteins. The membrane portion of these vesicles are comprised of amphiphilic molecules that
aggregate and cause deformations to the membrane, that result in budding process. This can
potentially rupture the membrane. (56)(57) Computational research is being conducted to better
understand this process. (43)
These same principles apply to lipids aggregating on materials that are not commonly
found in the body. Self-assembly of synthetic lipids have been observed on carbon nanotubes,
which seems to mimic the assembly properties of single-chain lipids that are used for
immobilization of histidine-tagged proteins. (42) A similar coating process is used for drug
treatment for cancer. (66)
It is important to note, these membranes and vesicles are comprised of different types of
lipids from phospholipids to neutral lipids like cholesterol, as well as containing different
proteins. Certain proteins, based on their adhesion strength to the membrane, can curve the
membrane, and are also aggregated together on the membrane (something that is very difficult to
characterize experimentally). (44) These are specialized proteins that aid in membrane remodeling
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process, that is essential for tasks such as endocytosis and protein sorting. There have been
coarse-grain models that aim at showing the attractive interaction (particularly aggregation) can
occur purely due to the curvature of the membrane. (47) This curvature is not only affected by
proteins. Lipid composition, nanoparticles, and viruses can play a larger role in the shape of lipid
membrane. (45) (48) (49) (59) (60) (67)
Viruses take advantage of the way that proteins behave in on lipid membrane. Influenza’s
M2 protein is studied to understand it’s functional mechanism in channeling protons to break
down hydrogen bonds in histidine pairs. (50) (53) (61) Other viruses, such as West Nile, have lipid
envelopes, which are comprised of the host cells membrane, around the virus’s protein capsid.
(51)(52)

The project here is to focus more on different nanoparticles. This is explained further in

the following sections.

Nanomaterials
Over the last two decades, there has been an increase in research dealing with
nanomaterials ranging from medicine to nanoelectronics. This has fostered research many
different types of nanomaterials such as magnetic nanoparticles(13)(17), polymer-based
nanocapsules, quantum dots(14) and more.(15) Because of their size and other properties such as
attraction to the head (antimicrobial) groups of a lipid, many of these materials can deform
and/or penetrate a lipid membrane, and thus get entry into a cell. For example, Gold
nanoparticle-based antibiotics can kill bacteria like E. coli, while also having the bacteria
become more susceptible to the antibiotic. The belief is that the gold nanoparticle antibiotic is
targeting the E. coli at the cell division pathway. This also implies that there might be higher
barriers that will prevent resistance to evolve for the nanoparticle antibiotic versus its larger
4

counterpart. (1) This may be due to their size. Since nanoparticles are similar in size to materials
like proteins and viruses (21), and since they can exhibit a high surface area to volume ratio,
nanoparticles are able to bond to cell membrane, as well as pass through using the process of
endocytosis. This warrants the study of the nanoparticles with both the cell and the membrane
surrounding the cell. Gold nanoparticles, also, due to their plasmon-resonant absorption and
scattering in the near infrared, are great probes and contrast agents for both in vivo and in vitro
imaging. (10)
There are several factors that will affect the membranes deformation and penetration,
such as the NP’s density on the membrane and their solubility. Since NP’s are able to have high
surface area to volume ratio, the surface of the NP can be coated with different functional groups
that would aid the process of tracking and binding to cells, ultimately allowing for targeted drug
delivery and fluorescent biological labels.
As nanomaterials become more prevalent, their cytotoxicity becomes more and more of a
concern, which is still poorly understood. Carbon nanoparticles, for example, have been getting a
lot of attention due their light weight, tensile strength, as well as their thermal and chemical
properties.(2)(3) With these nanoparticles in particular, their shape, size, charge, surface chemistry,
complexity, as well as a myriad of other factors play a role in the potential toxicity.(11) Another
example is quantum dots. Even though they are composed of toxic elements, the use of quantum
dots in the medical field seems to be bearing fruit. Certain types of quantum dots have been
shown to affect the osmotic equilibrium of a cell. Also peptide-coated QD’s have been shown to
accumulate in the liver and spleen, in addition to the targeted area.(4) This shows that it is
important to properly study the affects of these nanoparticles to minimize the dangers that they
can have on human health. (11)
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Figure 2: This is from Xiaohua Huang’s paper “Cancer Cell Imaging and Photothermal Therapy
in the Near-Infrared Region by Using Gold Nanorods” showcasing the optical strengths of gold
nanorods. (5)
NanoSpheres
Several types of nanoparticles are studied interacting with these bilayers, nanospheres in
particular have been looked at. These nanoparticles are absorbed into the cell through a process
called endocytosis. For passive endocytosis, a ligand-coated nanoparticle can be used to model
how a virus would interact on a cell membrane. When considering nanospheres interacting with
a bilayer, factors ranging from size, attraction strength, to density of particles will determine the
way the nanospheres will interact with membrane. (19) If there is only one sphere, these factors
will determine the amount of wrapping the sphere will experience, whether it will endocytosis,
and how much the membrane will deform. One of the determining factors of whether
spontaneous endocytosis will happen, is if endocytosis will reduce the free energy of the system.
In previous simulations, nanospheres that are comparable in size to the bilayer have shown that
the adhesion of the nanoparticles to a bilayer causes the lipids in direct contact with nanoparticle
to have a higher conformational order, further meaning that the bending rigidity increases when
you add a nanoparticle to the membrane. In conjunction with this, these systems have partially
wrapped states that are also thermodynamically equilibrium states. (6)
6

As we add particles, it will cause clustering and aggregation depending on number of
particles. Depending on number of particles, the adhesion energy between the membrane head
particles and nanoparticle, the density of the lipids, the aggregation of the nanospheres can take
many different forms, from tubes chains to rings and v-shapes. For moderate values of the
bending modulus nanoparticles will form into linear chains, while for low bending modulus, they
will take up a triangular lattice. (6)

Figure 3: This is an example of the aggregation of nanosphere simulated by Eric Spangler, on a
lipid membrane that is much larger than the size of the spheres. The image on the right turns off
the visibility of the membrane
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Non-Spherical Nanoparticles
In the sphere case, the size of the particle has been studied to see its effects on
endocytosis. As we being to look at rods and capsules. The shape also begins to play an
important role in determining the endocytic pathways that the nanoparticle will take. It is
important to understand these effects because it helps determines the positive and negative
factors about cytotoxicity the nanoparticle. For example, gold nanorods are being studied as
method of targeted cancer therapy. The internalization pathways for these gold nanorods has an
impact on their bioactivity. The way that the gold nanorods are absorbed by cancer cells, stem
cells, and normal cells is important to determine what causes the difference in cytotoxicity
between these three cells. In this case, the pathways were similar, which suggested intracellular
localization was the deciding factor in the fate of the cancer cells rather then the endocytic
pathway. (7) These gold nanorods uptake into the cell has been shown to decrease as the aspect
ratio of the nanorod increases. (12)
For nanocapsules, there have been studies done using a ligand-receptor model, where the
membrane is 2D, to study the endocytic pathways a nanocapsule will follow. Having a 2D
membrane is way to understand how a nanoparticle that is very larger compared to the
membrane and is much bigger than the width of the membrane will interact with said membrane.
In these studies, it determined that the size of the nanoparticle determines whether or not
endocytosis will complete, while the shape will determine the path. The shape, in this case, refers
to the aspect ratio of the length to the radius of the nanocapsule. As the shape is made more and
more elongated, the particle initially lays down on the membrane, and as it gets wrapped, it is
rotated to the vertical position, until finally separating from the membrane. (8)
This concept of the shape of a nanoparticle effecting the wrapping involved, is also true
for ellipsoid particles (Both oblate and prolate). Looking at only the wrapping of the
8

nanoparticle, and not the endocytosis, as particles shape changes from a oblate ellipsoid to a
prolate ellipsoid, the bending energy for a wrapping membrane decreases, but as the prolate
ellipsoid begins to the thin out, there is gradual climb in the bending energy. (9)

Objectives
The way that spherical nanoparticles are wrapped and how they aggregate on a
membrane has been studied heavily. Nanorods have also been investigated in a similar regard.
There is an understanding in the formations that occur when these nanoparticles are placed on
lipid bilayer. The goal of this research project was to look at the nanocapsules, a cylinder with
hemisphere caps on both ends. We wanted to investigate how several factors determined the
wrapping of the nanocapsules, such as the length, radius, and number of particles. These particles
resemble the use of certain bioconjugates on bacteria such as E. coli and provide a way to study
aggregation within that context. And while there have been studies that have looked at the
endocytic pathway of similarly shaped particles, albeit much at much larger length scales, this
study aims to look at the wrapping and aggregation of the nanocapsules
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Chapter 2: Model and Numerical Method
Lipid Molecules are comprised of one head group and two tail groups. The head groups
are hydrophilic, and the tail groups are hydrophobic. In this model, each of these groups are
represented by a soft ball. Similarly, the nanoparticles are constructed from small balls similar to
that of the lipid head and tail particles. There are harmonic interactions that deal with the bond
between the lipid balls as well as the balls of the nanoparticle. A three-body interaction is
calculated to determine the bending rigidity of the lipid, and two body interaction is used to
determine the potential between neighboring balls. These three interactions contribute to the
interaction potential, which is given by the following equation. (6)
𝛼𝛼

𝛼

𝛼

𝑖
𝑖
U({𝐫𝐢 }) = ∑ 𝑈0 𝑖 𝑗 (𝑟𝑖𝑗 ) + ∑ 𝑈𝑏𝑜𝑛𝑑
(𝑟𝑖,𝑖+1 ) + ∑ 𝑈𝑏𝑒𝑛𝑑
(𝑟𝑖−1 , 𝑟𝑖 , 𝑟𝑖+1 )

𝑖,𝑗

𝑖,𝑗

(1)

𝑖,𝑗

𝛼𝛼

∑𝑖,𝑗 𝑈0 𝑖 𝑗 (𝑟𝑖𝑗 ) is a two body interaction between two particles, i and j, and is given by
𝛼𝛽

𝛼𝛽

(𝑈𝑚𝑎𝑥 − 𝑈𝑚𝑖𝑛 )(𝑟𝑚 − 𝑟)2
𝛼𝛽
+ 𝑈𝑚𝑖𝑛
2
𝑟
𝛼𝛼
3
2
∑ 𝑈0 𝑖 𝑗 (𝑟𝑖𝑗 ) =
𝛼𝛽 (𝑟𝑐 − 𝑟)
𝛼𝛽 (𝑟𝑐 − 𝑟)
−2𝑈𝑚𝑖𝑛
+ 3𝑈𝑚𝑖𝑛
𝑖,𝑗
(𝑟𝑐 − 𝑟𝑚 )3
(𝑟𝑐 − 𝑟𝑚 )2
0
{

𝑖𝑓 𝑟 ≤ 𝑟𝑚
𝑖𝑓 𝑟𝑚 < 𝑟 ≤ 𝑟𝑐

(2)

𝑖𝑓 𝑟 > 𝑟𝑐

𝛼𝛽

,where 𝑈𝑚𝑎𝑥 > 0 for a given pair (𝛼, 𝛽), 𝑟𝑚 is the equilibrium distance, and 𝑟𝑐 is the cut-off
𝛼𝛽

distance. When 𝑈𝑚𝑖𝑛 is negative, there is a short-range attraction between two of type 𝛼 and 𝛽,
where 𝛼 and 𝛽 can be a tail, head, or nanoparticle ball. This is only the case when both are tail
𝛼𝛽

balls, or one is a head ball and the other is a nanoparticle ball, otherwise 𝑈𝑚𝑖𝑛 = 0. This allows
for the stable formation of lipid bilayers, and for the adhesion of the nanoparticles to the bilayer.
(6)
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𝛼𝛽

𝑈𝑏𝑜𝑛𝑑 (𝑟) is the harmonic interaction for bonds between balls of the lipid molecule and the bonds
between the balls of the nanoparticle. This is given by,

𝛼𝛽
𝑈𝑏𝑜𝑛𝑑 (𝑟)

𝛼𝛽

𝛼𝛽

2
𝑘
𝛼𝛽
= 𝑏𝑜𝑛𝑑 (𝑟 − 𝑎𝑏 )
2

(3)

𝛼𝛽

, “where 𝑘𝑏𝑜𝑛𝑑 is the bond stiffness and 𝑎𝑏 is the preferred bond length” (6).
𝛼

𝑖
𝑈𝑏𝑒𝑛𝑑
(𝑟𝑖−1 , 𝑟𝑖 , 𝑟𝑖+1 ) is the potential energy for the three-body interaction that determines the

rigidity of the lipids, and is given by the following:
𝛼

𝛼

𝑖
(𝑟𝑖−1 , 𝑟𝑖 , 𝑟𝑖+1 ) =
𝑈𝑏𝑒𝑛𝑑

𝑖
𝑘𝑏𝑒𝑛𝑑
𝑟𝑖,𝑖−1
̇ 𝑟𝑖,𝑖+1 2
(𝑐𝑜𝑠𝜃𝑜 − (
))
2
𝑟𝑖,𝑖−1 𝑟𝑖,𝑖+1

(4)

𝛼

𝑖
, where 𝑘𝑏𝑒𝑛𝑑
is the bending rigidity constant and 𝜃𝑜 is the desired splay angle. (6)

The nanoparticles are arranged in a face-center-cubic lattice with stiff harmonic bonds. The
lattice vectors for this structure are given by:
𝑎1 =

𝑎
(0,1,1)
2

(5)

𝑎2 =

𝑎
(1,0,1)
2

(6)

𝑎3 =

𝑎
(1,1,0)
2

(7)

11

Figure 4: harmonic interactions for bonds inside the lipid, three body interaction for bending
rigidity, and two body interaction between neighboring balls

Figure 5: This is an example of a Nanocapsule of Radius = 3 and Length = 7
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Figure 6: This is an example of the construction of the lipid bilayer. The red particles represent
the tail particles, while the gray represent head particles.

Numerical Approach
In this model, Molecular Dynamics is used to move particles according Newtons Law of
Motion in conjunction with a Langevin Thermostat. The Langevin dynamics mimics the
presence of solvent. The equations of motion are given by,
𝑟̇𝑖 (𝑡) = 𝑣𝑖 (𝑡)

(8)

𝑚𝑣̇ 𝑖 (𝑡) = −∇i 𝑈({𝑟𝑖 }) − Γ𝑣𝑖 (𝑡) + 𝜎Θ𝑖 (𝑡)

(9)

, where is m is the mass of each ball, Γ is the coefficient of friction, and 𝜎Θ𝑖 (𝑡) is a random force
that keeps the system in thermal motion (representing a thermal bath), and is dictated by
following correlation,
〈Θi (𝑡)〉 = 0

(10)

〈Θ𝜇𝑖 (𝑡)Θ𝑗𝑣 (𝑡′)〉 = 𝛿𝜇𝑣 𝛿𝑖𝑗 𝛿(𝑡 − 𝑡 ′ )

(11)
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, where u, v represents x, y, or z components/direction. The random force keeps the system in
thermal motion, and in conjunction with the dissipative force, it functions as the thermostat and
achieves thermal equilibrium. In other words, Γ and 𝜎 are related using the fluctuation𝜎2

dissipation theorem, giving Γ = 2𝑘 𝑇. This insures that the fluctuations and dissipations negate
𝑏

each other over time. During each timestep of the simulation the Verlet-Velocity method is used
to determine the equations of motion for each particle. (6)

Simulation Parameters
This model incorporates times, length, and energy as the base units. Verlet-Velocity is
method that calculates both position and velocity in each step. Since, we want to keep our
calculation in base units and focus on the scale of each parameter, we employ the VerletVelocity method with Γ =

√6𝑚
,
𝜏

rather than the explicit form we have earlier, where m continues
1

to be the mass of each ball, 𝜏 is the time scale and is given by 𝜏 =

𝑚 2
𝑟𝑚 ( 𝜖 )

, where 𝑟𝑚 is the

length scale, and 𝜖 is the energy scale.(6)
The lipid bilayers are composed of 20,000-60,000 lipid molecules. The bilayer is kept at
constant zero tension, with a density of lipids, 𝜎 ≈ 3.11𝑟𝑚−2 . The area of the membrane and the
pressure are kept constant. (6)
Simulations are done at different adhesion strengths between the nanoparticles and the
𝑛ℎ
lipid heads, ranging from |𝑈𝑚𝑖𝑛
| = .1𝜖 𝑡𝑜 1𝜖. Some of the simulations are done using an
𝑛ℎ
annealing process, where the 𝑈𝑚𝑖𝑛
is slowly raised to determine the transition point between to

states of the system.. Below are the interaction values between particles in our simulations:(6)
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ℎℎ
𝑡ℎ
𝑛𝑡
𝑈𝑚𝑎𝑥
= 𝑈𝑚𝑎𝑥
= 𝑈𝑚𝑎𝑥
= 100𝜖,

(12)

ℎℎ
𝑡ℎ
𝑛𝑡
𝑈𝑚𝑖𝑛
= 𝑈𝑚𝑖𝑛
= 𝑈𝑚𝑖𝑛
= 0,

(13)

𝑡𝑡
𝑈𝑚𝑖𝑛
= −6𝜖,

(14)

𝑛ℎ
𝑈𝑚𝑖𝑛
= −Ε,

(15)

𝑡𝑡
𝑛ℎ
𝑈𝑚𝑎𝑥
= 𝑈𝑚𝑎𝑥
= 200𝜖,
ℎ𝑡
𝑡𝑡
𝑘𝑏𝑜𝑛𝑑
= 𝑘𝑏𝑜𝑛𝑑
=
𝑛𝑛
𝑘𝑏𝑜𝑛𝑑
=

2800𝜖

100𝜖
2
𝑟𝑚

,

(16)
(17)

,

(18)

ℎ
𝑘𝑏𝑒𝑛𝑑
= 100𝜖,

(19)
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Chapter 3: Results
Single Nanocapsule
The first case we considered is that of a single nanocapsule placed on a square lipid
membrane constructed of 25,000 lipids to 50,000 lipids depending on the size of the
nanocapsule. The membranes length is roughly 3 to 4 times the total length of the nanocapsule.
This is done to ensure that there are minimal edge effects, since we use periodic boundary
conditions.
In the initial set up for the membrane, the individual molecules are placed uniformly in
the system. Once the system gets going, the membrane expands due to the interactions between
all the molecules as well as do to the temperature of the system. If there was no nanoparticle on
the membrane, it takes roughly 5,000 – 10,000 tau for the membrane to reach equilibrium
(depending on the size of the membrane).
We determine whether the membrane has reached equilibrium by looking at the area of
the membrane. The membrane is forced to stay in roughly a square shape, and as the simulation
progresses, the membrane initially grows (preserving the square shape) and then begins to
equilibrize in area, which coincides with the system reaching equilibrium. As stated previously,
this take roughly 5,000 to 10,000 tau. Once we add in a nanoparticle, the same principle applies.
The area of the membrane grows initially, but as the nanoparticle bounds with the membrane,
and depending on how it is wrapped, or if there is a orientation change of nanoparticle, the
membranes area can either shrink or grow. However, once the area equilibrizes, that is generally
the final state of the system. With a single nanoparticle, this can happen in 20,000 to 40,000 tau
depending on the size of the membrane and the size of the nanoparticle. There are other
indicators for the equilibrium of a system such as the potential energy of the system reaching
equilibrium.
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Our initial look is at nanocapsules with a Radius = 3, and lengths ranging form a value of
1 to 20. Note that length refers to the length of the capsule between the two hemispheres and
doesn’t not include the length of the hemispheres. For example, a nanocapsule of radius = 3 and
length = 1, would have a total length from end to end of 7. We place these nanoparticles, above
the lipid membrane right below where the interaction cut off is. When the simulation begins, the
nanoparticle drops to bind with the lipid membrane, and the depending on the |Umin|, will go
under various amounts of wrappings and rotations.
In this initial look, we find that there is a phase transition for the single particle case. The
first state is where the nanocapsule lays horizontally on the membrane, this is for lower values of
|Umin| and for higher values the nanocapsule gets in encapsulated by the membrane and in a
vertical position, perpendicular to the plane of the membrane, as shown in Figure 7. We used an
annealing process to determine where the transition between the two states happens. In this
annealing process, we ran the simulation at particular |Umin|, generally a value that was confirmed
to be in the horizontal state, and let the system reach equilibrium. We would then increase the
|Umin| by a step of .05, observe the change on the particle, let the system reach equilibrium, and
repeat.
For lower values of |Umin|, roughly around .3 for most of the nanocapsules with radius of
3, the membrane experience very little deformation caused horizontally lying capsule. As the |Umin|

increases, this deformation also increases. The nanocapsule is wrapped more and more by the

lipid membrane, and would stay relatively parallel to the plane of the membrane. When the |Umin|
get high enough, there is a sharp transition from the parallel state to the perpendicular state as
shown in Figure 8. One end of the nanocapsule pushes down on the membrane, to go into the
vertical state. As this happens the membrane on the side of the nanocapsule fills in around the
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unwrapped portion on the nanocapsule, starting the at the descending end, almost in the zipper
fashion. This process will only last at most 1,000 tau.
As can be seen, when the |Umin| is before the transition point, the angle of the nanocapsule
is close to 90 degrees with the z-axis, once the |Umin| is raised to a sufficient value during the
annealing process, the angle makes a sharp transition to being close to 0. Each |Umin|, is given
25,000 – 40,000 tau to ensure that equilibrium is reached for that value of |Umin| during the
annealing process. Figure 9, shows the |Umin| for which this transition happens as a function of
the length of the nanocapsule.
The way the angle is determined in for both Figure 8 and Figure 9 is by creating a vector
that represents the Nanocapsule. The vector is determined from one end of the nanocapsule to the
other end. This is done at every recorded time step after the completion of the simulation. This is
then compared to the z-axis, using the dot product between the z-axis the nanocapsule vector.
When the angle between the z-axis and nanocapsule is 90 degrees, the nanocapsule is in the
horizontal state, and when the angle is 0 degrees, the nanocapsule is in the vertical state. This can
be confirmed visually for majority of the nanocapsules. Nanocapsules with a length of 1 are
harded to confirm visually.
When increasing the |Umin| past the transition point, there is a neck that forms above the
nanocapsule in the membrane. As the |Umin| continues to rise, the neck pinches inward. This
pinching continues until it closes off, and the nanocapsule finishes undergoing endocytosis. This
process can shift up and down the curve depending on the radius of the caps on the nanocapsule
as shown by Figure 19. As you increase the radius, the closer you get to endocytosis. The
nanocapsule that is at a radius of 9 at a |Umin| = .4, has already experienced endocytosis, while
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one of radius of 5 has only just entered the vertical state, and one that is of radius 3 would only
still be in the horizontal state.

Multiple Nanocapsules
As we add more nanocapsules to the system, we studied the way that the nanocapsules
aggregated on the membrane. Since we are using periodic boundary conditions, adding
nanoparticles in principle means increasing the nanocapsule density on the the lipid membrane.
With our intial look, we want to avoid high particle densities, and have our nanoparticles near the
center of a lipid membrane much larger than the total length of the nanocapsules. In the case of
two nanocapsules, they are placed on a membrane that ranges from 35,000 lipids to 70,000
lipids, and allowed to aggregate. The two nanocapsules meet at their ends, and at low values of
|Umin|, they slightly deform the membrane around them with the largest deformation being at
their aggregation point. As the |Umin| increases the deformation increases as well, and the
aggregation point of the two nanocapsules sinks into the membrane while the other ends of the
capsules stay near the upper portion of the membrane. This forms a v-shape as shown in Figure
10. As the |Umin| increases further the angle between the two nanocapsules decreases until they
sink deep enough into membrane and the membrane forces them part. Portions of the membrane
fill in-between the nanocapsules, starting above the aggregation point. During the process of the
membrane separating the two nanocapsules, the angle between them increases, until they are
separated and eventually made parallel. Figure 11 demonstrates this for two different length of
nanocapsules. Figure 12, show the angle between the two nanocapsules vs |Umin|. Both figures
show that there are two transition points in the two particle system. The first one occurs when the
nanocapsules have been encapsulated enough to have the lipid membrane slip in-between them.
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The second transition occurs when the membrane has split the nanocapsules apart, are separately
encapsulated. But even in this case, the deformation that occurs above the nanocapsules on the
membrane is still conjoined between the two nanocapsules. Even though they are both
individually wrapped, the distance between the two nanocapsule is kept very small compared to
the length of the nanocapsules.
In the beginning of the annealing process, where the two nanocapsules join and begin to
dip into the lipid membrane, the shape the nanocapsules form is a v-shape. Due to the shape, and
the connection point of the two nanocapsules, the possible shapes are limited to v-shapes with
different angles. This also occurs in the spherical case, even though there are more degrees of
freedom in the spherical case. Figure 13, shows a side by side comparison of the spherical case
with the nanocapsules case. One way to understand this, is to view the nanocapsules as a series
nanospheres. In this way, it makes sense, why there would be similar states between the two
cases. This would also explain further similarities showcased later.
As we, add more nanocapsules to the system, they imbed themselves further into a vshape, creating a smoother curve for the aggregation, becoming more of a u-shape and getting
closer to having the same states as the sphere case. Figure 13, shows the comparison between the
v-shape created by the 2 nanocapsules case and the v-shape created during nanosphere
simulations, Figure 14, shows the comparison between a ring state for the nanospheres and the 3
nanocapsule case. This continues for more particles as well, the v-shape and u-shape continue to
appear for the 4 nanocapsule case, 5 nanocapsule case, and 9 nanocapsule case as well. As we
add more nanocapsules, the shape becomes smoother, although there are some situations that
still have the sharp v-shape, generally when the number of nanocapsules is even. Looking at
Figure 17, we see that there is a change between a v-shape to a u-shape as the |Umin| increases
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from .4 to .5. Similar to the two particle case, the nanoparticles are squeezed together forcing a
rigid v-shape, but once they have been pushed in sufficiently and made a large enough
deformation onto the lipid membrane, the membrane begins to fill in between the two arms of
the v-shape to get a more complete encapsulation. Then like the two particle case, the filling in
spreads the nanocapsules apart creating more of a ring/u-shape that also occurs in the spherical
cases. This is further shown in Figure 18 and 19. As the |Umin| increases, a more defined and
narrow neck forms, the particles are more deeply invaginated, and the membrane pinches at
center of the u-shape.
Another important aspect to note, in all of the case nanocapsules cases, once the particles
have aggregated, they all form a neck that tends to persist as the |Umin| increases, and tends to
increase and becomes more prominent as the |Umin| increases. It also narrows as |Umin| increases.
This is potentially the path that theses cases will take for endocytosis, once the neck narrows
enough. We have seen this in the one particle case already. The way pathway for the endocytosis
for the one particle case is that first it lays flat on the membrane, then transitions into a vertical
state, where a neck forms and begins to thin until finally having the nanocapsule endocytose
When we add many more particles, such that the density of nanocapsules on the
membrane is very high, we have these u-shapes and v-shapes link up to create long chains as
shown in Figure 15. Note that all other simulations have been done such that the density of
nanocapsules on the membrane are low. There is plenty of room on the lipid membrane for the
other simulation for the edge effects of the periodic boundary conditions to be minimal. For the
29 particle case in Figure 15, this is not the case. The simulation in this case connects
nanocapsules on opposite sides of the system, and the nanocapsules are spread through most the
membrane. Much like the previous cases, the deformation caused by the nanocapsules increases
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with |Umin|. Since there are many particles, the deformations is much larger for lower |Umin|
compared to other cases. This is better exemplified between the two, three, four, five, and nine
particle cases. When there are more particles, the system in more deeply entrenched state
compared to the fewer particle state. For example, for the value of |Umin| =.5, where membrane
has already filled in between 4 nanoparticles of radius = 3 and length = 3, the two particle at the
same conditions is still in the process of being squeezed together. Similar to how we can view a
nanocapsule as a series of nanospheres, we can consider that the size of the particles has a
cumulative effect. Each individual nanoparticle deforms the membrane a certain amount.
Looking at the being of our simulation, nanoparticles are place randomly above the lipid
membrane. Once they bind to the membrane, they cause their individual deformations to the
membrane, and as the nanoparticles aggregate, the deformations merge.

22

Figure 7: Above is a nanocapsule with Radius = 3 and Length = 3. The right two images are at
|Umin| = .5 (horizonatal state) and the left two images are at |Umin| = .7 (Vertical State)

Figure 8: This is graph of Angle vs Time(10 Tau). This is for a nanocapsule of Radius = 3 and
Length = 3. Each value of |Umin| goes through 25,000 tau. This graph shows a sharp transition at
|Umin| = .65 at Time(approx.) = 76,000 tau
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Figure 9: This is a graph of Length vs |Umin|, for when a nanocapusle will undergo the transition
from horizontal to vertical. All of the nanocapules used for this graph had a Radius = 3. Any |Umin| - length combination along and above the curve will be in the vertical state, while below the
curve will produce the horizontal case

Figure 10: Two Nanocapsule of Radius = 3 and Length = 3 at |Umin| = .6 aggregated in v-shape
configuration
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Figure 11: The right set of images are of two nanocapsules of Radius =3 Length = 9. The left
images are of Radius = 3 and Length = 7. Both sets range from |Umin| = .5 to |Umin| = .9, with
increasing |Umin| as you proceed down the images.
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Figure 12: This shows the angle between two nanocapsules as a function of |Umin|. All of
Nanocapsules are of Radius 3, and the lengths are 3,5,7, and 9 as indicated by the legend.

Figure 13: This is a comparison between sphere simulations done by Eric Spangler and the two
nanocapsule case (Radius = 3, Length = 3, |Umin| = .5).

26

Figure 14: This is a comparison between sphere simulations done by Eric Spangler and the three
nanocapsule case (Radius = 3, Length = 5, |Umin| = .5).

Figure 15: This is an example of 29 Nanocapsules of Radius = 3 and Length = 3 where the
density of nanocapsules on the membrane is high

Figure 16: This is an example of a 9 Nanocapsules of Radius = 3 and Length = 3. The left image
is at |Umin| = .6 and the right image |Umin| = .7

27

Figure 17: This is an example of a 4 Nanocapsules of Radius = 3 and Length = 3. The left image
is at |Umin| = .4 and the right image |Umin| = .5

Figure 18: This is an example of a 4 Nanocapsules of Radius = 3 and Length = 9 at |Umin| = .5
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Figure 19: This is an example of a 4 Nanocapsules of Radius = 3 and Length = 5. From Left to
Right the |Umin| = .5, |Umin| = .6, |Umin| = .7

Figure 20: The left image is Radius = 9 and Length = 7, and right image is at the same length at
Radius = 5. Both are at |Umin| = .4
|
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Chapter 4: Conclusion
Nanomaterials provide a wide range of unique properties that can aid in treatment of
virus and strengthen current imaging techniques. They can potentially play a very important role
in new medical techniques. For this reason, knowing how they will interact in the body becomes
very important.
When determining how they will interact in the body, notions of shape and adhesion
potential energy become very important. Some important shapes are spheres, rods, and capsules.
This project took a look at capsules to determine the way they will interact with a lipid
membrane that is much larger than the nanoparticle. In the one particle case, we determined that
there was a phase transition as you increase the adhesion strength between the nanocapsules and
the lipid head groups. The transition was for the nanocapsule lying flat on the membrane to being
vertically engulfed by the membrane. This resembled the tube shape that can occur when
multiple nanospheres are wrapped by a lipid membrane as shown in Figure 3. As we added more
particles, the resemblance to the sphere can increases. Two nanocapsules produce a similar vshape that can occur in the nanosphere case as well. This continues as we add more
nanoparticles. The shape more closely resembles other configurations you would see in the
sphere case. The number of nanocapsules will also determine how smooth that shape will be.
This shows us that there is similarity on how the nanocapsules and the nanospheres are treated on
the lipid bilayer and implies that the nanocapsule can be thought of as many nanospheres
connected. Although, that notion does not fully complete the picture of how the nanocapsules
will behave, since they have additional rigidity, it does provide a closer look at the elements in
play during the interaction between nanocapsules and lipid membranes.
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